Literature DB >> 12359265

Electrophysiological actions of gamma-aminobutyric acid and clomethiazole on recombinant GABA(A) receptors.

Rachael M Nelson1, A Richard Green, Atticus H Hainsworth.   

Abstract

Clomethiazole is a gamma-aminobutyric acid (GABA)-mimetic agent with anticonvulsant, sedative and neuroprotective properties. The pharmacological actions of clomethiazole that underlie its functional profile have not been fully explored, but are known to result from an interaction with the GABA(A) receptor. Here, we present a quantitative electrophysiological study of clomethiazole action at human recombinant GABA(A) receptors. Whole-cell currents were recorded from murine L(tk-) cells stably transfected with either alpha1, beta1 and gamma 2 or alpha1, beta2 and gamma 2 GABA(A) receptor subunits. Clomethiazole directly activated GABA(A) currents in alpha1/beta1/gamma 2- and alpha1/beta2/gamma 2-containing cells, with EC(50) values of 0.3 and 1.5 mM, respectively. A low concentration of clomethiazole (30 micro M) also potentiated the action of GABA in both cell types, equivalent to a 3-fold increase in potency and up to 1.8-fold increase in maximal current. Both direct activation and gamma-aminobutyric acid potentiation are likely to contribute to the in vivo profile of clomethiazole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359265     DOI: 10.1016/s0014-2999(02)02233-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.

Authors:  Zhihui Qin; Jia Luo; Lawren VandeVrede; Ehsan Tavassoli; Mauro Fa'; Andrew F Teich; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-07-24       Impact factor: 7.446

2.  The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects.

Authors:  Horst Gann; Kerstin Hartig; Bernd Feige; Rigo Brueck; Fritz Hohagen; Gesa Weske; Dietrich van Calker; Dieter Riemann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-05-06       Impact factor: 5.270

3.  The vitamin-E analog trolox and the NMDA antagonist MK-801 protect pyramidal neurons in hippocampal slice cultures from IL-1beta-induced neurodegeneration.

Authors:  Ann-Cathrin Radesäter; Sara Johansson; Caroline Oberg; Johan Luthman
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors.

Authors:  Marcello Usala; Sally Anne Thompson; Paul J Whiting; Keith A Wafford
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

5.  Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.

Authors:  Jia Luo; Sue H Lee; Lawren VandeVrede; Zhihui Qin; Sujeewa Piyankarage; Ehsan Tavassoli; Rezene T Asghodom; Manel Ben Aissa; Mauro Fà; Ottavio Arancio; Lan Yue; David R Pepperberg; Gregory R J Thatcher
Journal:  BMC Neurosci       Date:  2015-10-19       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.